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Research Paper

The functional and structural associations of aberrant
microglial activity in major depressive disorder
Jasmine D. Cakmak, MSc; Linshan Liu, MSc; Stefan E. Poirier, MSc;
Betsy Schaefer, BSc; Raju Poolacherla, MD; Amer M. Burhan, MBChB, MSc;
Priyadharshini Sabesan, MBBS, MRCPsych; Keith St. Lawrence, PhD;
Jean Théberge, PhD; Justin W. Hicks, PhD; Elizabeth Finger, MD;
Lena Palaniyappan, MBBS, PhD; Udunna C. Anazodo, PhD
Background: Major depressive disorder (MDD) is a debilitating mental illness that has been linked to increases in markers of inflammation, as well as to changes in brain functional and structural connectivity, particularly between the insula and the subgenual anterior cingulate cortex (sgACC). In this study, we directly related inflammation and dysconnectivity in treatment-resistant MDD by concurrently meas
uring the following: microglial activity with [18F]N-2-(fluoroethoxyl)benzyl-N-(4phenoxypyridin-3-yl)acetamide ([18F]FEPPA) positron
emission tomography (PET); the severity of MDD; and functional or structural connectivity among insula or sgACC nodes. Methods:
Twelve patients with treatment-resistant MDD (8 female, 4 male; mean age ± standard deviation 54.9 ± 4.5 years and 23 healthy controls
(11 female, 12 male; 60.3 ± 8.5 years) completed a hybrid [18F]FEPPA PET and MRI acquisition. From these, we extracted relative standardized uptake values for [18F]FEPPA activity and Pearson r-to-z scores representing functional connectivity from our regions of interest.
We extracted diffusion tensor imaging metrics from the cingulum bundle, a key white matter bundle in MDD. We performed regressions to
relate microglial activity with functional connectivity, structural connectivity and scores on the 17-item Hamilton Depression Rating Scale.
Results: We found significantly increased [18F]FEPPA uptake in the left sgACC in patients with treatment-resistant MDD compared to
healthy controls. Patients with MDD also had a reduction in connectivity between the sgACC and the insula. The [18F]FEPPA uptake in the
left sgACC was significantly related to functional connectivity with the insula, and to the structural connectivity of the cingulum bundle.
[18F]FEPPA uptake also predicted scores on the Hamilton Depression Rating Scale. Limitations: A relatively small sample size, lack of
functional task data and concomitant medication use may have affected our findings. Conclusion: We present preliminary evidence linking a network-level dysfunction relevant to the pathophysiology of depression and related to increased microglial activity in MDD.

Introduction
Major depressive disorder (MDD), characterized by recurrent cognitive and emotional dysfunction, is one of the
most prevalent psychiatric disorders and a major contributor toward reduced quality of life.1 Many therapies are successful at treating MDD, but a significant proportion of patients fail to respond and are considered to have a
treatment-resistant profile.
Although the pathophysiology of MDD is not yet fully understood, dysconnectivity among various brain networks
that facilitate cognitive and emotional information processing
is thought to be a critical mechanism. This dysconnectivity
appears to involve various parts of the brain, with a high degree of interindividual variability and limited spatial overlap
among patients.2 Not all network-related changes may be

causally relevant, but current theories emphasize the role that
certain affected brain networks may play in influencing treatment outcomes for depression, as well as its long-term
course.3 For example, certain prefrontal regions (dorso
medial, ventrolateral and ventromedial) appear to be rel
evant for predicting treatment response to medications and
cognitive behavioural therapy.2,4
Two critical brain regions for predicting therapeutic response and prognosis in MDD are the subgenual anterior cingulate cortex (sgACC) and the insula. Increased activity in
the sgACC can predict resistance to treatment (this hyper
activity normalizes with an improvement in symptoms5,6)
and can also be altered by treatment.7–9 Similarly, the metabolic state of the insula, modifiable through MDD therapies,
appears to be a critical determinant of response to various
forms of treatment in MDD.2,10,11 The insula, through its
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e xtensive connectivity with other brain regions (including the
sgACC) assigns salience to emotional and sensory stimuli
and regulates interoception,12,13 the disruption of which has
been associated with the emergence of several cardinal features of MDD.14–16
Dysfunction of the immune system, and the resulting aberrant load of neuroinflammation, is increasingly considered to
be an important pathway toward depressive illness, at least
in a subgroup of patients with MDD. Aberrant neuroinflammation has major implications for treatment outcomes; conventional antidepressants that have few to no anti-inflammatory
properties may not be effective, resulting in a treatment
resistant profile.17,18 Microglia play an integral role in driving
the neuroinflammatory response in the brain, and they have
been shown to have increased activity in MDD17,19–21 using
positron emission tomography (PET) ligands such as [18F]N2-(fluoroethoxyl)benzyl-N-(4phenoxypyridin-3-yl)acetamide
([18F]FEPPA) that bind to translocator protein (TSPO), a receptor expressed on the mitochondrial membrane of activated microglia.
Microglia may alter brain network connectivity through
means such as synaptic pruning,22 which likely has downstream consequences for connectivity among brain regions.
Previous studies have linked peripheral and postmortem
markers of inflammation with alterations in resting-state
functional connectivity in MDD. 23,24 However, although
excessive microglial activity has been demonstrated in vivo
in MDD, we do not know if this finding has functional or
structural consequences for the brain networks relevant to
the pathophysiology of depression.
Subjective depressive consequences resulting from neuroinflammatory triggers in healthy volunteers are mediated by
neural activity in the insula and sgACC.12,25 The dysfunction
of the anterior cingulate cortex (ACC) — particularly its subgenual division — and its altered connectivity with the insula
have been consistently reported in MDD.26–31 The insula, the
ACC as a whole and the sgACC show increased microglial
activity and density in MDD and late-life depression,17,20,21 although some studies have shown no differences or decreased
glial cell count.32–34 It has become apparent that the status of
microglial activation in MDD (or treatment resistance) is not
well delineated, particularly in key frontolimbic regions (i.e.,
the insula and the sgACC). In the current study, we focused
on the microglial activity of the insula and sgACC and the
connectivity anchored on these nodes in MDD because of
their connectivity, roles in treatment resistance and known
inflammatory states.
Several white matter tracts have been implicated in depression. The cingulum bundle is associated with pain, emotion
and executive function35,36 and carries a large fraction of projections from the ACC toward regions that are critical in the
pathophysiology of depression, such as the hippocampus37
and the parahippocampal gyrus.38 In MDD, alterations in the
integrity of this tract have been reported and associated with
axonal degeneration, familial risk, illness severity and persistence.39–45 In particular, patients with later-life depression
have been observed to have a higher load of white matter
lesions affecting the cingulum,46 and deep-brain stimulation
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of the cingulum bundle is a promising option for treatment
resistant MDD.47–49 We investigated the potential relationship
between microglial activity and cingulum integrity in MDD.
The current study investigated these relationships in
4 parts using a hybrid approach of PET and MRI: (1) demonstrating aberrant microglial activity in the sgACC and insula
in patients with MDD compared to healthy controls, (2) relating microglial activity to the observed severity of depression,
(3) evaluating the functional connectivity between the sgACC
and the insula in MDD using functional MRI, and (4) establishing the relationship between aberrant microglial activity
and the structural and functional connectivity of the affected
regions in patients with MDD compared to healthy controls.
We hypothesized that in patients with treatment-resistant
MDD, increased microglial activity in the sgACC and insula
(measured with [18F]FEPPA) would be associated with disrupted connectivity among these 2 nodes, and with the severity of MDD.

Methods
Participants
We recruited 12 patients with treatment-resistant depression,
aged 45 years and older, who had been referred to the therapeutic brain stimulation clinic at the Parkwood Institute
Mental Health Care Building (London, Ontario, Canada)
b etween December 2017 and March 2019. We defined
“treatment-resistant” as failing to respond to 2 or more courses
of antidepressants.50 Using previously reported effect sizes for
the association between microglial activity and the severity of
depression (r = +0.63)17 and assuming a power of 80%, with a
type I error rate of 5% and a type II error rate of 20%, we estimated that a minimum of 12 patients would be sufficient to
detect regional-level differences. For controls, we included
PET and MRI data from 23 age-matched healthy volunteers
(free of psychiatric disorders and cognitive impairment) who
had been recruited for an ongoing dementia imaging study.
Patients were referred to a specialized depression treatment unit (“hard-to-treat” depression service attached to a
therapeutic brain stimulation research facility). The diagnosis
of depression was established using a sequence of consensus
from the referring physician’s diagnostic impression and the
psychiatrist in the depression clinic, who directly assessed
the patient based on the MDD criteria from the Diagnosis and
Statistical Manual of Mental Disorders, 5th edition, before referring them to the research study.51 Two research psychiatrists
(A.B. and L.P.) reviewed case histories to assess suitability for
inclusion. Healthy controls were assessed for current or previous health incidents.
Up to 2 weeks before the scan, patients underwent the Montreal Cognitive Assessment, the Beck Depression Inventory, the
Clinical Global Impression Severity scale and the 17-item Hamilton Depression Rating Scale (HAM-D).52–54 Information about
patients’ medication history, level of education, onset of depression and treatment response were collected at study
enrolment (Appendix 1, Table S1, available at www.jpn.ca/
lookup/doi/10.1503/jpn.210124/tab-related-content).
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Participants were diagnosed as having treatment-resistant
MDD or as healthy with no previous history of mental health
disorders. Patients were free of confounding neuropsychiatric conditions (including Alzheimer disease and related dementia) and had no known history of ongoing infections,
persistent inflammation or immunological diseases (e.g.,
arthritis or autoimmune disease). Participants with contra
indications for MRI (e.g., claustrophobia) or PET (pregnant or
lactating) were excluded. Given the known differences in
TSPO binding affinity common to second-generation TSPO
PET ligands because of a single nucleotide polymorphism,
participants with low-affinity binding of the ligand to TSPO
(less than 10 % of the population) were excluded to reduce
intersubject variability.55 Genotyping of the TSPO-related
polymorphism was performed at the London Regional Gen
omics Centre at Robarts Research Institute, and individual
TSPO polymorphism status was included as a covariate in
the statistical analysis.
This study was approved by the Western University
Health Sciences Research Ethics Board and conducted in accordance with the Declaration of Helsinki ethical standards.
All participants provided written informed consent.

PET and MRI scans
Participants were scanned once using a 3 T Biograph mMR
scanner (Siemens Healthineers) with a 12-channel PETcompatible head coil to obtain both PET and MRI data in tandem. Each participant was injected with an intravenous bolus
of [18F]FEPPA (mean dose ± standard deviation: 185 ± 5 MBq
[5 ± 0.5 mCi]), synthesized at Lawson Health Research Institute following a reported method.56 Dynamic PET images
were acquired for 90 minutes in list mode, starting immediately after injection of the tracer. The 60- to 90-minute postinjection frames were reconstructed to 6 frames of 5 minutes
using Siemens e7 tools and an iterative algorithm (ordered
subset expectation maximization algorithm; 3 iterations,
21 subsets, 2 mm full width at half-maximum Gaussian filter,
2.5 zoom factor, 344 × 344 × 127 matrix representing 2 × 2 ×
2 mm3 voxels) and corrected for decay, scatter, dead time and
attenuation using a magnetic-resonance-based approach.57
We used a T1-weighted 3-dimensional magnetizationprepared rapid gradient echo sequence (slice thickness 1 mm,
repetition time 2000 ms, echo time 2.98 ms, flip angle 90°, acquisition matrix 256 × 256, field of view 256 mm) to generate
1 mm isotropic voxel tissue masks for PET attenuation and
for partial volume error correction, masking, coregistration of
MRI with PET and normalization of images into Montreal
Neurological Institute (MNI) space. We acquired functional
MRIs (fMRIs) when participants were at rest with their eyes
open in a 2 mm isotropic resolution covering the whole brain
with 64 interleaved axial slices (slice thickness 3 mm, repetition time 2500 ms, echo time 30 ms, flip angle 90°, acquisition
matrix 80 mm × 80 mm, field of view 240 mm). We obtained
a total of 164 volumes; we discarded the first 6 to account for
magnet stabilization. We acquired a 10-minute diffusionweighted imaging (DWI) scan using a single-shot echo
planar imaging sequence with the following parameters:

64 diffusion-encoding directions, b values 0 and 1000 s/mm2,
2 × 2 × 2 mm3 isotropic voxels. We acquired 2 b0 images with
opposite phase-encoding directions to correct for susceptibilityinduced distortions in DWI.

PET and MRI processing
We conducted preprocessing of the PET images using the
SPM12 toolbox (www.fil.ion.ucl.ac.uk) and in-house MATLAB
(2018b; MathWorks) scripts. To compensate for motion, PET
time frames were aligned to the first frame and averaged to
1 image volume using the SPM realignment function and
converted to standardized uptake value (SUV) images.
The T1-weighted images were segmented into grey matter,
white matter and cerebrospinal fluid (CSF) using the segmentation tool in the computational anatomy toolbox (CAT12).58
The grey matter segment was then smoothed using an 8 mm
kernel to permit improved alignment of MRI to PET. We applied a whole-brain mask generated from the cumulative
sum of the grey matter, white matter and CSF segments to
the PET SUV images to remove extracerebral voxels. We corrected the SUV images for partial volume effects using the
Müller–Gartner method implemented in the PETPVE12 toolbox in SPM.59 To ensure that white matter and CSF signal
contamination were well compensated, the white matter and
CSF segments were eroded in MATLAB with morphological
filtering and connected component analysis using a 2 × 2
voxel size. We set point-spread function for partial volume
effect correction at 5 mm isotropic to model the point-spread
function of the PET and MRI scanner. The SUV images were
spatially normalized to MNI space following the unified segmentation method,60 smoothed using a Gaussian filter with a
full width at half-maximum of 10 mm and count-normalized
by the mean SUV in the primary motor cortex to create relative SUV (rSUV) maps.
We generated masks for the regional analyses from the
Automated Anatomic Labelling atlas (www.gin.cnrs.fr/en/
tools/aal/). The masks were eroded by 2 voxels as described
above to restrict inclusion of voxels outside of the region of
interest (ROI) and minimize misalignment of ROIs to individual PET images. We extracted mean rSUV values from the
left and right sgACC and insula grey matter for statistical
analysis. The sgACC has been reported to have higher micro
glial activity in voxel-wise studies of MDD, and the insula
has been reported to have higher microglial activity in ROI
studies.17,20,21 We also explored other subregions of the ACC
(pregenual and supracallosal) in an exploratory manner and
report uncorrected results.
We preprocessed the fMRI images using the default direct
processing pipeline in CONN toolbox (MATLAB 2018b;
www.nitrc.org/projects/conn; RRID:SCR_009550); we
included motion parameters as regressors. We performed a
seed-based analysis using the sgACC as a seed region between patients and controls (4 controls were excluded
because of frontal artifacts), including covariates (age and
sex). We extracted Pearson r-to-z scores for statistical analysis, representing functional connectivity between the sgACC
and the insula.
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We preprocessed the DWI data using an in-house pipeline
to generate diffusion tensor imaging (DTI) scalar maps as well
as fractional anisotropy (FA), mean diffusivity (MD), a xial diffusivity (AD) and radial diffusivity (RD) maps.61 The DTI
scalar maps were normalized to MNI space using a 3-step
registration algorithm (consisting of rigid, affine and deformable transformations to a standard MNI T1 1 mm template) in
ANTs.62 We performed region-based analyses of DTI scalars
by calculating mean FA, MD, AD and RD values in the cingulum bundle white matter pathway using regional masks from
the Johns Hopkins University white matter atlas.63 Although
multiple metrics are available from DTI, increased AD has
been associated with axonal integrity64,65 and increased extracellular water content. Increased extracellular water content is
a biomarker of neuroinflammation,66 and microglia aid in
engulfing axonal debris.67,68 Therefore, we chose AD as the
primary DTI index of interest for our analysis.

Statistical analysis
Covariates of no interest included age, sex and TSPO polymorphism status. We conducted nonparametric testing of
demographic differences between diagnostic groups using
either a χ2 test (sex, TSPO) or a Kolmogorov–Smirnov test
(age, injected dose). We performed multiple linear regressions including covariates of no interest to assess differences
in regional microglial activity (rSUV) and functional connectivity (z scores) to determine the effect of diagnostic status.
Given the 4 ROIs chosen a priori, we used a Bonferroni-
corrected statistical threshold of p < 0.0125 for significance.
We performed a multiple linear regression per ROI with nonlinear locally estimated scatterplot smoothing (LOESS) to
a ssess the relationship between [18F]FEPPA uptake and
HAM-D scores, and between [18F]FEPPA uptake and DTI
measures of the cingulum bundle, adjusting for covariates as
above (threshold p = 0.05).
To test the effects of functional connectivity on microglial activity, we first derived a single factor representing all functional

connectivity variables (left sgACC to left insula; left sgACC
to right insula; right sgACC to left insula; right sgACC to
right insula; left sgACC to right sgACC; left insula to right
insula) using principal component analysis. Next, we ran a
nonlinear regression across the whole sample predicting left
sgACC microglial activity with the connectivity variable derived from the principal component analysis and covariates
of no interest. We included the connectivity variable and age
as nonlinear (LOESS) predictors, and the categorical variables of diagnostic status, sex and TSPO status as linear predictors. We ran the same models (excluding diagnostic status as a predictor) on patients and controls separately. We
used nonlinear regressions to relate functional connectivity
with [18F]FEPPA uptake, because both increased69 and decreased70,71 connectivity have been reported in preclinical
and clinical studies of inflammatory markers, indicating the
likelihood of a U-shaped relationship between microglial
activity and functional connectivity.
We ran all statistical tests using SAS 9.4M7 (SAS Institute)
with a statistical threshold of p = 0.05, except for power
analyses, which were run with mgcv and emon packages in
R 4.1.2 (R Core Team).

Results
Participant demographics can be found in Table 1. Statistical
summaries of all tests (including power) can be found in
Table 2, Table 3 and Table 4.
We found a significant increase in [18F]FEPPA uptake in
patients compared to controls in the left sgACC (regression
analysis; t = 2.684, p = 0.012). All other regions except the
right pregenual ACC showed higher [18F]FEPPA uptake compared to controls but did not survive correction (Figure 1).
[18F]FEPPA uptake from the left and right insula was a significant predictor of HAM-D scores (regression analysis; left
p = 0.039, right p = 0.037; Figure 2).
The z scores representing functional connectivity between
the sgACC and the insula revealed no significant reduction

Table 1: Participant demographics
Depression
n = 12

Control
n = 23

Significant difference
between groups

Sex, n

8 female, 4 male

11 female, 12 male

No

Age, yr

54.9 ± 4.5

60.3 ± 8.5

No

Level of education, yr

17.1 ± 4.0

NA

NA

8 HAB, 4 MAB

12 HAB, 11 MAB

No

222.7 ± 50.0

204.6 ± 49.9

No

Montreal Cognitive Assessment score†

26.5 ± 2.1

NA

NA

HAM-D score

18.9 ± 7.1

NA

NA

Suicidality, %

66.7

NA

NA

Psychosis, %

8.3

NA

NA

30.4 ± 13.8

NA

NA

Variable*

TSPO status, n
Injected dose [18F]FEPPA, MBq

Age of onset, yr‡

[18F]FEPPA = [18F]N-2-(fluoroethoxl)benzyl-N-(4phenoxypyridin-3-yl) acetamide; HAB = high-affinity binder; HAM-D = 17-item Hamilton Depression Rating Scale; MAB = mixed-affinity
binder; NA = not applicable; TSPO = translocator protein.
*All means include ± standard deviation.
†Missing data from 1 participant.
‡Missing data from 2 participants.
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in pair-wise connectivity (regression analysis; left sgACC–left
insula p = 0.47, right sgACC–right insula p = 0.053, left
sgACC–right insula p = 0.059, right sgACC–left insula p =
0.21, all p values uncorrected; Figure 3).
Across the entire sample, we found that sgACC–insula
functional connectivity was a significant nonlinear predictor
of left sgACC microglial activity (regression analysis; p =
0.044; Figure 4). When we investigated patients and controls
separately, we found that functional connectivity was a signifi
cant nonlinear factor in explaining left sgACC [18F]FEPPA uptake for both groups (regression analysis; patients p = 0.015,
controls p = 0.035). Interestingly, higher [18F]FEPPA uptake

r elated to optimal (near-average) connectivity in healthy controls, but in patients with MDD, both reduced and increased
connectivity occurred with higher [18F]FEPPA uptake.
Finally, we assessed the relationship between microglial
activity in the left sgACC and white matter integrity of the
cingulum bundle. We found that AD (a measure of unidirectional diffusion) from the left cingulum bundle significantly
predicted microglial activity of the left sgACC in a linear
model (regression analysis; p = 0.023; Figure 5A), but FA, MD
and RD did not significantly predict microglial activity
(regression analysis; FA p = 0.84; MD p = 0.07; RD p = 0.17;
Figure 5B to D).

Table 2: Statistical summary, Figure 1 and Figure 3*
Outcome

Difference ± SD
(controls – patients with MDD)

t (1 − α/2g, n − k)

p value

Power

1

rSUV, left sgACC

–0.165 ± 0.062

–2.684

0.012

0.986

1

rSUV, right sgACC

–0.077 ± 0.071

–1.086

0.29

0.934

1

rSUV, left insula

–0.091 ± 0.064

–1.409

0.17

0.739

1

rSUV, right insula

–0.100 ± 0.069

–1.438

0.16

0.814

3

Connectivity, left sgACC–left insula

0.057 ± 0.078

0.725

0.47

0.407

3

Connectivity, right sgACC–right insula

0.136 ± 0.067

2.024

0.053

0.838

3

Connectivity, left sgACC–right insula

0.139 ± 0.070

1.973

0.059

0.792

3

Connectivity, right sgACC–left insula

0.092 ± 0.072

1.288

0.21

0.796

Figure

MDD = major depressive disorder; rSUV = relative standard uptake value; SD = standard deviation; sgACC = subgenual anterior cingulate cortex; TSPO = translocator protein.
*Group differences are presented after adjustment for age, sex and TSPO in a regression model. Bonferroni adjustments were applied to p values for simultaneous parameter estimates.
α = 0.05, g indicates the number of parameters to be estimated jointly, k indicates the number of variables in the model and n − k represents degrees of freedom.

Table 3: Statistical summary, Figure 2 and Figure 5*
Figure

Outcome

Predictor (mean)

Change ± SE

t

p value†

Power

2A

HAM-D

rSUV, left insula (1.37760)

–36.675 ± 14.670

–2.500

0.039

0.880

2B

HAM-D

rSUV, right insula (1.30117)

–30.151 ± 11.871

–2.540

0.037

0.840

5A

rSUV, left sgACC

Axial diffusivity of the
left cingulum (0.00091)

3.282 ± 1.042

3.150

0.023

0.683

5B

rSUV, left sgACC

Fractional anisotropy of the
left cingulum (0.30021)

–0.154 ± 0.735

–0.210

0.84

0.419

5C

rSUV, left sgACC

Mean diffusivity of the
left cingulum (0.00068)

2.110 ± 0.982

2.150

0.07

0.839

5D

rSUV, left sgACC

Radial diffusivity of the
left cingulum (0.00057)

1.238 ± 0.809

1.530

0.17

0.833

HAM-D = 17-item Hamilton Depression Rating Scale; rSUV = relative standard uptake value; SE = standard error; sgACC = subgenual anterior cingulate cortex.
*Represented are changes in microglial activity of the left sgACC associated with mean increase in diffusion tensor imaging scalars of the cingulum bundle, and changes in functional
connectivity of the sgACC associated with mean increase in insular microglial activity.
†p value associated with the absolute value of t.

Table 4: Statistical summary, Figure 4*
Nonlinear association
Figure

Outcome

Independent variable

Population

F

df

p value

Power

4B

Mean rSUV, left sgACC

PCA Pearson r-to-z scores

All

3.77

1.755

0.044

0.938

4C

Mean rSUV, left sgACC

PCA Pearson r-to-z scores

Patients with MDD

12.30

0.944

0.015

0.744

4D

Mean rSUV, left sgACC

PCA Pearson r-to-z scores

Controls

4.46

2.266

0.035

0.815

df = degrees of freedom; MDD = major depressive disorder; PCA = principal component analysis; rSUV = relative standard uptake value; sgACC = subgenual anterior cingulate cortex.
*Nonlinear association between the left sgACC mean rSUV and Pearson’s r-to-z scores (PCA-derived) for each population.
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Figure 1: Differences in mean rSUV by region of interest. Regions of interest included the left and right sides of (A) the entire anterior cingulate
cortex (violet); (B) the ACC pregenual (green), subgenual (red) and supracallosal (blue) subregions; and (C) the insula (yellow). (D) Regions of
interest chosen a priori for hypothesis testing are highlighted in red boxes. We ran linear regressions for each region of interest (including covariates), finding significant differences between patients with major depressive disorder (n = 12) and controls (n = 23) in the left subgenual
ACC (p = 0.012) when partial volume correction was used. ACC = anterior cingulate cortex; rSUV = relative standardized uptake value.

Discussion
In the current study, we demonstrated 3 key findings rel
evant to the neuroinflammation hypothesis of treatmentresistant MDD: significantly increased microglial activity
in the left sgACC occurred in patients being treated for
MDD; the higher the microglial activity in the insula, the
less severe the HAM-D scores; and in MDD, left sgACC
microglial activity influenced the functional connectivity
between the sgACC and the insula, as well as the axonal
integrity of the cingulum bundle.
Setiawan and colleagues17 have found increases in micro
glial density in the prefrontal cortex, the insula and the ACC
using [18F]FEPPA; other groups have replicated these findings using analogous [11C]-PBR28.20 In the current study, we
localized these findings to the sgACC as a specific site of
increased [18F]FEPPA uptake. The findings of Su and colleagues21 using a voxel-wise search also corroborate our
localization to the sgACC.
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We found that microglial activity from the left and right insula predicted HAM-D scores, but this relationship was negative. Previous studies have reported an increase in severity
of depression with increasing microglial activity,17 but individuals with increased neuroinflammation showed better
treatment outcomes as well.72 Our sample consisted of patients who were receiving long-term treatment; depression
severity was low among those with higher microglial activity. It is possible that the inverse relationship we have reported is more reflective of post-treatment improvement in
outcomes in a subset of patients inclined to have higher
neuroinflammation (as reported by Attwells and colleagues72) or of neuroprotective microglial activity.73 The
relationship between symptom severity and microglial activity may also differ according to stage of treatment, phase
of illness or treatment-resistant profile.
Levels of sgACC–insula functional connectivity were
likewise dependent on diagnostic status, which has previously been elucidated.74 As hypothesized, we found that
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Figure 2: The relationship between mean rSUV from the insula and HAM-D scores. A linear regression including age as a nonlinear factor
(LOESS) and sex as covariates found that [18F]FEPPA activity (represented by rSUV) in (A) the left insula (p = 0.039) and (B) the right insula
(p = 0.037) significantly predicted HAM-D scores in patients with major depressive disorder (n = 12). [ 18F]FEPPA = [18F]N-2-(fluoroethoxl)
benzyl-N-(4phenoxypyridin-3-yl) acetamide; HAM-D = 17-item Hamilton Depression Rating Scale; LOESS = locally estimated scatterplot
smoothing; rSUV = relative standardized uptake value.
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Figure 3: Differences in functional connectivity between the sgACC
and the insula. A linear regression (including age and sex as covariates) found that functional connectivity (represented by P
 earson
r-to-z scores) did not differ significantly between patients with major
depressive disorder (n = 12) and controls (n = 19). We found a borderline significant difference in functional connectivity between the
right sgACC and the right insula (p = 0.053), and between the left
sgACC and the right insula (p = 0.059). sgACC = subgenual anter
ior cingulate cortex.

functional connectivity between the sgACC and the insula
was significantly associated with microglial activity from
the left sgACC in both patients and controls. To our know
ledge this was the first study to use PET and MRI to investigate the functional consequences of [18F]FEPPA uptake in
patients with MDD. A study investigating the network
pathophysiology as it relates to neuroinflammation (also
using PET and MRI) in Alzheimer dementia found that individuals with increased radioligand binding had abnormal functional connectivity.75 Although this study was conducted in patients with Alzheimer dementia, later-life
MDD and cognitive impairment are highly correlated (depression is an early risk factor for dementia), and the current results highlight a possible neuroinflammatory basis
for both conditions.
We note that patients with MDD had a V-shaped relationship between microglial activity and functional connectivity
that was distinct from healthy controls. The healthy controls
showed an initial increase in microglial activity with rising
functional connectivity, a peak and a subsequent decrease. In
patients with MDD, we observed both an increase and a decrease in functional connectivity in conjunction with higher
levels of microglial activity. On a speculative note, these observations may reflect 2 different states of the microglia: a neurotoxic state (seen in patients with MDD), where higher levels
are related to extremes of functional connectivity, and a neuroprotective or surveillance state (seen in healthy controls),
where optimal functional connectivity requires sufficiently
high microglial activity, maintaining neuronal communi
cation.76 A dynamic pattern of microglial activation, particularly early increased activity and a later switch to decreased
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Figure 4: The relationship between mean rSUV and functional connectivity. We ran nonlinear regressions that included PCA-derived functional connectivity factor and age as nonlinear factors (LOESS), and linear covariates of no interest, to assess the impact of sgACC–insula
functional connectivity (represented by Pearson r-to-z scores) on [18F]FEPPA activity (represented by rSUV). (A) We used all 6 pair-wise connectivity variables between the bilateral sgACC (red) and the insula (yellow) to create a single principal factor. (B) In the full sample (n = 31),
increasing functional connectivity was associated with a sinusoidal-like change in [18F]FEPPA activity (p = 0.044). (C) In patients with MDD
(n = 12), increasing functional connectivity was associated with first a decrease and then an increase in [18F]FEPPA activity (p = 0.015). (D) In
controls (n = 19), we again found a sinusoidal relationship between connectivity and activity (p = 0.035). [18F]FEPPA = [18F]N-2-(fluoroethoxl)
benzyl-N-(4phenoxypyridin-3-yl) acetamide; LOESS = locally estimated scatterplot smoothing; MDD = major depressive disorder; PCA = principal component analysis; rSUV = relative standardized uptake value; sgACC = subgenual anterior cingulate cortex.

activity, was identified in a previous study that chronicled the
transition from cognitively normal status to mild cognitive impairment to Alzheimer disease.76 The speculation presented
here needs further confirmation in a longitudinal hybrid PET
and MRI study using a larger cohort of adults with MDD and
age-matched and medication-naive healthy controls. For
now, the correlations detected here convey the possibility
that the network-level dysconnectivity often attributed to axonal integrity and asynchronous neuronal activity in depression relates to microglial integrity. The pathophysiological
changes attributed to neuronal function in “hard-to-treat”
depression may not be fully independent of glial changes.
When relating white matter macrostructural connectivity to
microglial activity, we found that AD (diffusion in a direction
parallel to the white matter tract) of the cingulum bundle was
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significantly associated with microglial activity in the sgACC.
At present, there is no consensus about the findings of specific
DTI metrics in MDD, and meta-analyses have posited that
characteristic patterns may be restricted to subsets of the disease.36,41 An increase in AD with increasing microglial activity
may denote alterations in white matter microstructure (i.e., axonal integrity), and because AD is associated with neuro
inflammation66 and microglia in particular,67,68 it may be that
neuroinflammation negatively affects the white matter integrity of the cingulum bundle. This relationship may signal increased axonal injury (prompting microglia to clear up axonal
debris) or chronic activation of microglia (which may facilitate
axonal degeneration). Furthermore, although FA, MD and RD
were not significantly associated with microglial activity, the
general trends we found were reflective of age-related patterns
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of axonal degeneration.77,78 This may indicate that microglia
have an effect similar to age, which lends added support to the
idea of a shared mechanism between Alzheimer disease and
depression.
Although the specifics of how microglia influence brain
connectivity are ambiguous at best, it is possible that micro
glia may alter connectivity through synapse pruning. Re
modelling of neuronal circuits is an important function of
microglia, along with their role in immune response. Abnormalities in this remodelling function can have negative effects
on synaptic plasticity, as well as on behaviour.22 The remodelling function is mediated by microglia–neuron crosstalk, a reciprocal communication that when dysregulated may be

involved in depression.22 Manipulation of the C-X3-C Motif
Chemokine Receptor 1 (CX3CR1) pathway — in which
microglia–neuron communication is prominent — can affect
and induce depressive-like behaviour in mice.79–81 Reduced
CX3CR1 signalling, (and therefore reduced transmission between the 2 cell types) can affect the efficiency of synapses in
transmitting signals and may result in modified connectivity,
although this can occur through many microglia–neuron signalling pathways, including microglial decline and senescence.82,83 Microglia have numerous states of activation, but
activation specific to inflammation has been linked with
altered synaptic current in hippocampal neurons, meaning
that there is some precedent to these findings.84,85
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Limitations

Conclusion

Our study had several strengths, including the use of hybrid
PET and MRI, which mitigated the interval-related confounds that can affect multimodal acquisition (improved spatial and temporal coregistration), correcting for genetic variations in TSPO status and the use of a second-generation
TSPO ligand.
This was an exploratory study geared at hypothesis generation. We were limited by the relatively small sample
size and lack of task-encoded fMRI data to further validate
the relevance of the observed functional dysconnectivity.
We chose a lenient p threshold to reduce type II errors in
this small sample. In addition, the inexhaustive age-matching
between groups, the absence of HAM-D and Montreal
Cognitive Assessment screening for controls and the recruitment of a cohort with MDD who were exposed to concomitant psychotropics and antidepressants could have affected the study findings.
Medications could have anti-inflammatory properties
that could alter intrinsic brain activity and influence functional states. Nevertheless, most analyses were sufficiently
powered.
The use of SUV and reference regions compared to other
PET quantification methods such as kinetic modelling and
supervised cluster analysis further limited the strength of our
findings, and employing these methods in the future will be
necessary to confirm our results.86
TSPO imaging is a promising noninvasive tool for the
investigation of in vivo responses to inflammation; nevertheless, there are inherent limitations to its use. Much like
other TSPO tracers commonly used to assess activated
microglia as an analogue of neuroinflammation, [18F]FEPPA
is known to show some proportion of nonspecific binding
to astrocytes and endothelial cells. It is not clear what the
ratio of binding between these cell types is, although the
contribution of TSPO from microglia may be several times
greater than that of astrocytes, and the contribution of
TSPO from these astrocytes has not yet been found to make
a significant contribution to the PET image.87 Furthermore,
microglial activation is described as proinflammatory or
anti-inflammatory, but this idea is shifting as a result of
emerging research on the ever-changing inflammatory state
or morphology of glial cells in response to the environment.
An increase in TSPO expression has been associated with
both proinflammatory and anti-inflammatory states, and
TSPO-specific radioligands are unable to distinguish between the different states.88,89 This could be because the
states exist in a continuum rather than a binary. It may also
be that these TSPO radioligands measure microglial density
rather than microglial activation.90,91 Such a lack of specifi
city with respect to inflammatory states may be a challenge
for other radioligands designed to image neuroinflammation by targeting other inflammatory processes besides
TSPO, including emerging radioligands that specifically
bind to microglia and not astrocytes.92 In addition, TSPO
imaging is constrained by a rs6971 gene polymorphism; we
adjusted statistically for this constraint in the current work.

Our study first highlights the central role that activated
microglia may play in key brain circuits to influence the mechanistic processes (axonal integrity, functional connectivity) and
behavioural phenotypes (symptom severity) that are relevant
to depression. Our work reinforces the importance of hybrid
PET and MRI as a translational neuroimaging tool. Linking
PET-based abnormalities to DTI- and fMRI-based networklevel dysfunction provides the context for interpreting the behavioural relevance of receptor- or cellular-level changes — a
crucial step toward generating a more systemic understanding
of the pathophysiology of psychiatric disorders.
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